دورية أكاديمية
Should lithium be used in children and adolescents with bipolar disorder?
العنوان: | Should lithium be used in children and adolescents with bipolar disorder? |
---|---|
المؤلفون: | Salazar de Pablo G; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Child and Adolescent Mental Health Services, South London and Maudsley NHS Foundation Trust, UK; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain. Electronic address: gonzalo.salazar_de_pablo@kcl.ac.uk., Young AH; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Kent, UK. |
المصدر: | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2024 May; Vol. 82, pp. 1-2. Date of Electronic Publication: 2024 Feb 03. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111390 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7862 (Electronic) Linking ISSN: 0924977X NLM ISO Abbreviation: Eur Neuropsychopharmacol Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Amsterdam : Elsevier, c1990- |
مواضيع طبية MeSH: | Bipolar Disorder*/drug therapy , Lithium Compounds*/therapeutic use, Humans ; Adolescent ; Child ; Antimanic Agents/therapeutic use |
مستخلص: | Competing Interests: Declaration of competing interest Dr Salazar de Pablo has received honoraria from: Janssen-Cilag, Lundbeck, Menarini and Angelini. Prof Young has received compensation for lectures or advisory boards from the following companies: AstraZeneca, Boehringer Ingelheim, Eli Lilly, LivaNova, Lundbeck, Sunovion, Servier, Janssen, Allegan, Bionomics, Sumitomo Dainippon Pharma, COMPASS, Sage, Novartis, and Neurocentrx. |
المشرفين على المادة: | 0 (Lithium Compounds) 0 (Antimanic Agents) |
تواريخ الأحداث: | Date Created: 20240204 Date Completed: 20240502 Latest Revision: 20240502 |
رمز التحديث: | 20240503 |
DOI: | 10.1016/j.euroneuro.2024.01.007 |
PMID: | 38310671 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1873-7862 |
---|---|
DOI: | 10.1016/j.euroneuro.2024.01.007 |